Stifel Maintains Hold on TransMedics Group, Raises Price Target to $130
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $115 to $130.
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $115 to $130.